The Lancet Gastroenterology & Hepatology in conversation with artwork

Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection

The Lancet Gastroenterology & Hepatology in conversation with

English - November 09, 2022 23:00 - 15 minutes - 10.6 MB
Life Sciences Science Education gut intestines ibs ibd bowel medicine research Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: James Alexander immune responses to COVID-19 vaccination in patients with IBD

Next Episode: Dan Turner on vedolizumab in children with IBD

Simon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection.

Read the full article:
Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT)

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv